N18 · Anemia Labs and Treatment Response

Dialysis nursing · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

An inadequate response is a reason to investigate the cause, not simply to keep increasing the dose.

Align anemia response with the treatment timeline. See the diagram description and full text below.
· Download full-size illustration (PNG) · Download Markdown · Read text version ·

Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.

Diagram description

Align anemia response with the treatment timeline. Dated laboratory results — Hemoglobin and iron markers; Recorded doses — Iron and ESA administration; Intercurrent illness or loss — Alternative explanations for change; Response review — Look for lag and request an authorized plan. A poor response is a question to investigate, not an automatic dose increase. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.

Text version

Make a dated response table

List Hb/date beside ESA dose actually given, IV iron/date, missed treatments, transfusion, hospitalization, and bleeding. A fall after missed doses and a fall despite escalating treatment raise different questions. Bring this timeline to the prescriber.

Read iron studies together

Interpret ferritin and transferrin saturation with inflammation, recent IV iron, and collection timing. High ferritin does not prove iron is available for red-cell production, and one unusual panel may need confirmation.

Look for an explanation

Ask about access bleeding, dark stools, infection, poor intake, fatigue, and dyspnea. Persistent low hemoglobin despite escalating ESA should trigger cause-based review, including iron restriction, blood loss, inflammation, and other diagnoses.

Trend trigger versus emergency

Hb rise >1 g/dL in 2 weeks, an unexpected fall, or the ordered hold threshold needs timely review. Chest pain, dyspnea at rest, syncope, major bleeding, or instability needs urgent assessment regardless of the Hb number.

Keep the target individualized

KDIGO 2026 anemia guidance is final. Treatment balances symptoms, transfusion avoidance, and medication risks; do not aim to normalize hemoglobin or independently increase ESA, iron, or transfusion exposure.

Ask why the response changed

Give Hb trend, ferritin/TSAT, recent iron timing, administration record, BP, and symptoms. Ask whether the next step is blood-loss/infection assessment, another cause investigation, an authorized dose change, or repeat testing—not simply more ESA.

Supporting evidence

Continue learning